Six biotech stocks trading below cash right now
The biotech stock market is currently in a tough spot, with many companies facing suppressed…
November 16, 2022 - 6 minutes
investment
The biggest private biotech investments in October 2022
The companies Tempus Labs, Oculis and VectorBuilder Biotechnology bagged the biggest biotech investments in October…
November 1, 2022 - 3 minutes
Amgen joining Evotec and TIAP to boost Canadian life science companies
Evotec SE and Toronto Innovation Acceleration Partners (TIAP) have expanded LAB150, their translational BRIDGE partnership,…
October 17, 2022 - 3 minutes
Big Idea Ventures announces cohort of 17 start-ups
Big Idea Ventures has revealed its latest accelerator cohort. Seventeen early-stage startups were selected for…
October 5, 2022 - 7 minutes
Pheon Therapeutics launches with $68M in series A funding for treatment of solid tumors
Pheon Therapeutics launched today (September 28) following the closing of a $68 million series A…
September 28, 2022 - 3 minutes
Novo Nordisk Foundation investing $200M for first quantum computer for life sciences research
The Novo Nordisk Foundation has awarded a grant of $200 million to establish the first…
September 21, 2022 - 5 minutes
Kamari Pharma raises $8M in investment for development of drugs for skin diseases
An $8 million investment has been raised by Kamari Pharma following investment from the Guangzhou-Israel…
September 19, 2022 - 3 minutes
Investment of €130M made by Merck’s MilliporeSigma for life-saving therapies
An investment of €130 million ($130 million) has been invested in Molsheim, France to strengthen…
September 8, 2022 - 2 minutes
The biggest private biotech investments in August 2022
The healthcare-focused companies Orna Therapeutics, F2G and Sironax bagged the biggest biotech investments in August…
September 7, 2022 - 3 minutes
Neurocrine to conduct placebo-controlled study to investigate potential new treatment for schizophrenia
A phase 2 clinical trial for the treatment of schizophrenia has been accepted by the…
August 5, 2022 - 3 minutes
Biosyntia closes a €11.5M round to launch world’s first bio-based vitamin B7
A bio-based vitamin B7 is the first product to be commercialized as biotech company, Biosyntia,…
July 8, 2022 - 3 minutes
Millions invested for progression of Lyme disease vaccine
Pfizer has agreed to invest €90.5 million ($95 million) towards a vaccination for Lyme disease. …
June 22, 2022 - 2 minutes
